Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.
Asami Y, Kobayashi Kato M, Hiranuma K, Matsuda M, Shimada Y, Ishikawa M, Koyama T, Komatsu M, Hamamoto R, Nagashima M, Terao Y, Itakura A, Kohno T, Sekizawa A, Matsumoto K, Kato T, Shiraishi K, Yoshida H.
Asami Y, et al. Among authors: yoshida h.
Br J Cancer. 2023 Apr;128(8):1582-1591. doi: 10.1038/s41416-023-02203-3. Epub 2023 Feb 16.
Br J Cancer. 2023.
PMID: 36797358
Free PMC article.